About Us

Adam J. Gordon, MD, MPH, FACP, DFASAM


Biography and Statement

Adam J. Gordon, MD, MPH, FACP, DFASAM

1. How would your election benefit ASAM and the field of addiction medicine?

My election to the ASAM Board of Directors as Director-at-Large will benefit ASAM and field of addiction medicine. In many ways, my prior experiences will allow me to bring unique “quadruple threat” expertise in addiction related activities to the Board. As described elsewhere in this nomination letter, I have demonstrated excellence in the field of addiction as 1) a clinician, 2) an investigator, 3) an educator, and 4) an advocate.

In sum, I have demonstrated expertise as a developer of institutional and national programs of clinical care to patients with addiction (clinician); as a leading clinical investigator in addiction science (investigator), as a leading educator of peers, trainees, and students in many different types of addiction educational programs (educator); and as a leader in organized medicine both in and outside of addiction societies and government and have advocated for patients and the field of addiction in national, regional, and local stakeholder, organization, government, and public arenas and entities (advocate). Through this “quadruple threat” approach, I have been able to mediate often-difficult interdisciplinary, interprofessional, and system issues involving clinical care and public policy.

I will bring an informed collaborative perspective to the Board. As I have already demonstrated to ASAM, I will also bring productivity to the Board. Finally, as I have done for government, scientific, and organizational entities, I will be able to represent the face of the organization (through public speaking, written communication, and social media) to its members, key external stakeholders, and the public. If elected to the Board I would hope to advance further the following activities ASAM to enhance the field of addiction medicine:

  1. Increase the representation of academic medicine and investigational scholarship within ASAM
  2. Increase the representation of health professional students and residents/trainees within ASAM
  3. Improve ASAM outreach to local, regional, and national organizations/entities who address pain, addiction and pain, and addiction education
  4. Improve the ability of ASAM to help with the transfer of scientific discoveries into real world health care settings
  5. Improve ASAM’s social media and media presence
  6. Advocate for prompt and appropriate reimbursement of addiction medicine clinical activities
  7. Improve ASAM’s relationship with the US Veterans Health Administration, the NIH, SAMHSA, and other governmental agencies
  8. Improve the interdisciplinary and “interprofessionality” of ASAM
  9. Enhance and continue to strength the relationship between the American Board of Preventive Medicine (Board for Addiction Medicine Specialty) and ASAM
  10. Be a fiduciary steward and leader for the organization.

With this nomination, I affirm that I will attend to all the duties outlined to be an ASAM Board of Director. In addition, it is important to note, that I (or my family) have absolutely no fiduciary or proprietary interests (and do not plan to have any interests) that would impair my ability—or appear to impair my ability—to be impartial member of the Board either now or in the past. In sum, I asked a colleague the other day if I should put my name up for consideration for the ASAM Board and asked what is (and could be) my greatest contribution to the Board and the field of addiction medicine. He responded, “YES! You are a 1) a nurturer, 2) a builder, and 3) a scholar.” That is a perfect summary of who I am. Thank you for considering me as a Director-At-Large position on the ASAM Board of Directors.

2. What are your greatest contributions to ASAM and the field of addiction medicine?

I have been a continuous member of ASAM since 1998. Since that time, I believe I have served ASAM admirably as an organizational leader. On the national level, I have served in a variety leadership roles. As an example, I have served as a Mentor and ASAM-representative Mentor of several mentoring programs. This includes, the Physician Clinical Support System (PCSS-) for Office-Based Opioid Treatment (PCSS-B), for Methadone (PCSS-M), for Medication Assisted Treatment (PCSS-MAT), and the HRSA-funded Opioid Addiction Treatment ECHO Project (OAT ECHO). I have been a Course Director and Faculty for dozens of Buprenorphine Certification Courses, including many that were ASAM sponsored. I have served ASAM in the production of a variety of scientific products, including serving on the Guideline Rating Committee for the 2015 ASAM National Practice Guideline for Medications for the Treatment of Opioid Use Disorder and serving several times as Section Editor for editions of the ASAM Principles of Addiction Medicine.

In 2005, I joined the ASAM’s Committee on Continuing Medical Education (CME) and through my leadership roles on this Committee I have exemplified my greatest contributions to the ASAM. In 2008, I was appointed as Co-Chair of the Committee and, in 2009, I was appointed Chair of the Committee by the ASAM Board of Directors. During my tenure in this leadership role, I successfully revitalized the Committee, chaired ad-hoc meetings and annual retreat meetings, and was a steward for the Committee’s success. During my tenure as Co-Chair and Chair, I assisted and authored three applications for re-accreditation of ASAM with the Accreditation Council for Continuing Medical Education (ACCME), the last in 2017. These applications were highly successful and ASAM received ACCME Re-accreditation with Commendation to ASAM, ACCME’s highest honor, during my stewardship.

Through my role on the CME Committee, I have been a member of several ASAM conference-planning committees and serve as the ASAM representative to the AATOD national meetings. I have been a faculty of a plethora of ASAM meetings, presented research and workshop at ASAM’s Annual Meetings, served as an ASAM mentor, and actively encouraged physician, non-physician, and trainee/student memberships. Locally, I have served as the Vice-President of the Pennsylvania Chapter, assisting with the revitalization of that Chapter and currently am revitalizing the Utah Society of Addiction Medicine. In addition, I believe I have admirably served as a champion and contributor to the field of addiction medicine as outlined in my short biography statement.

Additionally, I have authored over 163 peer reviewed articles in prominent journals, 60 peer-reviewed abstracts, 4 letters to the editor/commentaries, 13 books or book chapters, 10 reviews or guidelines, 55 non-peer-reviewed articles, and presented several hundreds of presentations and lectures across the US and internationally. I am an active teacher, serving in mentoring roles for dozens of trainees and faculty. I am also an acknowledged peer-mentor and leader in the VA, where I have led national programs to encourage the implementation of evidence-based addiction treatment, education of colleagues and trainees about addiction, and served on and authored national guidelines regarding addiction treatment and criteria for use of medications to treat addictions.

Finally, I am a program developer. I have developed and directed a multitude of addiction fellowship programs, addiction inpatient and outpatient consultation services, and primary care medical homes for patients who have addiction or are homeless. As a testament to my leadership skills at ASAM and the field of addiction medicine, I received a distinction as Fellow at ASAM (FASAM) in 2008 and was an inaugural Distinguished Fellow at ASAM (DFASAM), in 2016.

Biographical Sketch

I grew up in Springfield, Missouri. In 1995, I graduated with a Bachelor of Arts Degree (BA) in Biological Sciences from Northwestern University. In 1995, I graduated with a Medical Degree (MD) from the University of Pittsburgh School of Medicine.

In 1998, I completed an internal medicine residency in internal medicine and in 2000, completed a Fellowship in General Internal Medicine from the University of Pittsburgh Medical Center and the VA Pittsburgh Healthcare System and completed a Master of Public Health (MPH) degree from the University of Pittsburgh’s Graduate School of Public Health. I am a board-certified internal medicine (American Board of Internal Medicine) and addiction medicine physician (American Board of Preventive Medicine). I am Certified Medical Review Officer (CMRO) first through the American Association of Medical Review Officers (AAMRO) and then the Medical Review Officer Certification Council (MROCC).

I was honored as a Fellow in the American College of Physicians (FACP) and a Distinguished Fellow from ASAM (DFASAM). From 1998 to 2017, I rose to the academic rank of Professor of Medicine and Clinical Translational Sciences and served as an Advisory Dean at the University of Pittsburgh School of Medicine and Core Faculty at the VA’s Center of Innovation (CoIN), Center for Health Equity Research and Promotion (CHERP) at the VA Pittsburgh Healthcare System.

In 2017, I assumed the Elbert F. and Marie Christensen Endowed Research Professorship and was awarded rank of Professor of Medicine and Psychiatry (with tenure) at the University of Utah School of Medicine. In addition, I was appointed Chief of Addiction Medicine and Core Faculty at another VA CoIN, the Informatics, Decision-Enhancement and Analytic Sciences (IDEAS2), at the VA Salt Lake City Health Care System.

I have made major contributions to addiction science, education, and clinical care. I have a 20-year record of accomplishment of conducting research on the quality, equity, and efficiency of health care for vulnerable populations and have been fully funded as a health services, implementation scientist throughout my career. A major theme of my research included examining the efficacy, effectiveness, and implementation of evidence-based identification, assessment, and treatments for patients with addiction disorders.

I have received primary and secondary efforts on grants from the NIH, AHRQ, PCORI, VA, SAMHSA and many Foundations. I have published over 185 peer-reviewed articles and presented, authored, or edited hundreds of other non-peer reviewed and peer reviewed papers in prominent journals, books, book chapters, and presentations at national and international scientific conferences. As an example, I have been a Section Editor for ASAM’s Principles of Addiction Medicine the last three editions.

Nationally in the VA, I am the Director of the Buprenorphine in the VA (BIV) Initiative and the Medication Addiction Treatment in the VA (MAT-VA), national consult services to increase the implementation of buprenorphine and other opioid use disorder treatments through the conduct of monthly national webinars, monthly newsletters, and fielding inquiries across the nation.

I also am the Director of the National Coordinating Center for the VA Office of Academic Affiliations Advanced Interdisciplinary Fellowship in Addiction Research and Treatment. In this capacity, I have been responsible for coordinating professional and educational activities for over 20 Fellows annually. I am the Editor-in-Chief of the journal Substance Abuse, a leading journal in addiction scholarship. I have Directed and been a clinician for countless clinical programs involving providing clinical care to patients with addiction and who are homeless. I have also led my peers, serving as President (and many other officers) of the Allegheny County Medical Society (one of the youngest in the 100+ year history of the organization), Trustee of the Pennsylvania Medical Society (PaMedSoc), delegate to the PaMedSoc and the AMA annual meetings, and numerous other leadership positions in these and other professional organizations.

I have received a plethora of national and local recognition and honors for my research, mentoring abilities, and clinical contributions all in the area of addiction related work. I continue to see patients in dedicated, continuity-of-care primary care/addiction clinics weekly as well as consultant on patients with pain and addiction.